Cargando…
Centrally Acting ACE Inhibitor Use and Physical Performance in Older Adults
BACKGROUND: There is conflicting evidence regarding the role of angiotensin-converting enzyme inhibitors and physical function. While some studies show improvements in muscle strength and physical function, others show no significant difference or decreased performance. This ambiguity could be due t...
Autores principales: | George, C.J., Hall, C.B., Weiss, E.F., Verghese, J., Neptune, E., Abadir, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111793/ https://www.ncbi.nlm.nih.gov/pubmed/36946705 http://dx.doi.org/10.14283/jfa.2023.10 |
Ejemplares similares
-
Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia
por: Gao, Yang, et al.
Publicado: (2013) -
Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer’s disease
por: Fazal, Karim, et al.
Publicado: (2017) -
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
por: Jia, Hongpeng, et al.
Publicado: (2021) -
Genome-Wide Analysis in Drosophila Reveals the Genetic Basis of Variation in Age-Specific Physical Performance and Response to ACE Inhibition
por: Gabrawy, Mariann M., et al.
Publicado: (2022) -
Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
por: Dobrowolski, Chrisanna, et al.
Publicado: (2023)